Bosutinib: a novel src/abl kinase inhibitor for chronic myelogenous leukemia

J Adv Pract Oncol. 2013 Nov;4(6):451-5. doi: 10.6004/jadpro.2013.4.6.8.
No abstract available

Publication types

  • Review